A new trial in the United Kingdom has discovered a highly sensitive bone marrow test that could revolutionise the diagnosis and treatment of acute myeloid leukemia, which is a rare cancer that affects your bone marrow and blood. This can potentially improve the lives of thousands diagnosed with this aggressive blood cancer, mostly young people.